PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.98%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.67%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-77.54%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-77.54%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-23.37%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.75%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.75%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
10.30%
Share count expansion well above OGI.TO's 8.89%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.30%
Diluted share count expanding well above OGI.TO's 4.86%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-213.44%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-293.67%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
-49.02%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-38.88%
Negative 3Y CAGR while OGI.TO stands at 0.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-73.69%
Negative 10Y OCF/share CAGR while OGI.TO stands at 60.87%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
63.22%
5Y OCF/share CAGR at 50-75% of OGI.TO's 89.49%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
80.56%
3Y OCF/share CAGR 1.25-1.5x OGI.TO's 67.88%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-1805.63%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-176.55%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
51.73%
Positive short-term CAGR while OGI.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
9259.09%
10Y equity/share CAGR above 1.5x OGI.TO's 433.02%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-35.28%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-58.67%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.30%
AR growth is negative/stable vs. OGI.TO's 28.53%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.84%
Inventory shrinking or stable vs. OGI.TO's 25.97%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.69%
Negative asset growth while OGI.TO invests at 17.49%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.28%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.29%
Debt shrinking faster vs. OGI.TO's 123.08%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-73.35%
Our R&D shrinks while OGI.TO invests at 42.11%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-19.29%
We cut SG&A while OGI.TO invests at 20.17%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.